Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase III Study Treatment of CLL B and C

This study has been completed.
Sponsor:
Information provided by:
French Innovative Leukemia Organisation
ClinicalTrials.gov Identifier:
NCT00535912
First received: September 26, 2007
Last updated: October 31, 2007
Last verified: September 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2006
  Estimated Primary Completion Date: No date given